Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-28 Wang Julia Aijun Chief Financial Officer Grant or award +61,750 143,299
2022-02-28 Riva Alessandro Director Grant or award · Share Option (Right to Buy) +22,581 22,581
2022-02-28 Dugan Margaret Director Grant or award · Share Option (Right to Buy) +22,581 22,581
2021-12-15 Wang Lai Global Head of R&D Grant or award +0 $30.13 $0 0
2021-12-15 Wu Xiaobin President, COO & GM China Grant or award +0 $30.13 $0 0
2021-12-14 Huang Jane CMO, Hematology Option exercise +1,500 $119.96 $180K 1,500
2021-12-14 Huang Jane CMO, Hematology Sale −300 $274.54 $82K 1,200
2021-12-14 Huang Jane CMO, Hematology Sale −300 $276.95 $83K 900
2021-12-14 Huang Jane CMO, Hematology Sale −500 $278.21 $139K 400
2021-12-14 Huang Jane CMO, Hematology Sale −100 $278.79 $28K 300
2021-12-14 Huang Jane CMO, Hematology Sale −200 $281.64 $56K 100
2021-12-14 Huang Jane CMO, Hematology Sale −100 $284.52 $28K 0
2021-12-14 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 211,276
2021-12-01 Huang Jane CMO, Hematology Sale −530 $357.32 $189K 519
2021-12-01 Huang Jane CMO, Hematology Sale −519 $362.45 $188K 0
2021-11-30 Huang Jane CMO, Hematology Grant or award +14,820 160,055
2021-11-30 Huang Jane CMO, Hematology Grant or award +1,049 1,049
2021-11-17 Huang Jane CMO, Hematology Option exercise +1,500 $119.96 $180K 1,500
2021-11-17 Huang Jane CMO, Hematology Sale −200 $376.16 $75K 1,300
2021-11-17 Huang Jane CMO, Hematology Sale −300 $377.14 $113K 1,000

Page 53 of 71 · 1,406 trades